Share on StockTwits

Illumina (NASDAQ:ILMN) Director Gerald Moeller sold 5,000 shares of the stock on the open market in a transaction dated Monday, June 30th. The shares were sold at an average price of $178.97, for a total value of $894,850.00. Following the transaction, the director now directly owns 17,367 shares in the company, valued at approximately $3,108,172. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Illumina from a “neutral” rating to an “outperform” rating in a research note on Tuesday, June 24th. They now have a $205.00 price target on the stock. Separately, analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Finally, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $146.71.

Shares of Illumina (NASDAQ:ILMN) traded up 2.33% during mid-day trading on Tuesday, hitting $182.70. The stock had a trading volume of 1,276,787 shares. Illumina has a 52 week low of $72.13 and a 52 week high of $183.30. The stock has a 50-day moving average of $164.0 and a 200-day moving average of $148.7. The company has a market cap of $23.458 billion and a P/E ratio of 125.56. Illumina also was the target of a significant decrease in short interest in June. As of June 13th, there was short interest totalling 10,265,824 shares, a decrease of 41.3% from the May 30th total of 17,495,888 shares. Currently, 8.1% of the company’s stock are short sold. Based on an average trading volume of 2,518,211 shares, the short-interest ratio is currently 4.1 days.

Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, April 22nd. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter in the previous year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 27.2% on a year-over-year basis. On average, analysts predict that Illumina will post $2.17 earnings per share for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.